CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections

Detalles Bibliográficos
Autores principales: Kwa, S, Sadagopal, S, Hong, J, Gangadhara, S, Basu, R, Lai, L, Iyer, S, Araki, K, Earl, PL, Wyatt, L, Villinger, F, Moss, B, Ahmed, R, Amara, RR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442088/
http://dx.doi.org/10.1186/1742-4690-9-S2-P365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442088/
http://dx.doi.org/10.1186/1742-4690-9-S2-P365

Ejemplares similares